Theragyn: Began Phase II study

Antisoma plc (EASD:ASOM), London, U.K. Product: Theragyn Business: Cancer Therapeutic category: Antibody, Cytotoxic Target: PEM ( polymorphic epithelial mucin) on cancer cells Description: Murine HMF...